Effect of cholinesterase inhibitors on active potassium influx in monkey erythrocytes.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D002087:Butyrates / Q000494:pharmacology; D002794:Choline / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D003650:Decamethonium Compounds / Q000494:pharmacology; D004912:Erythrocytes / Q000378:metabolism*; D000882:Haplorhini; D066298:In Vitro Techniques; D007531:Isoflurophate / Q000494:pharmacology; D007700:Kinetics; D008251:Macaca; D009388:Neostigmine / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D011188:Potassium / Q000097:blood*; D011194:Potassium Isotopes; D013438:Sulfhydryl Compounds / Q000378:metabolism; D013997:Time Factors
D002087:Butyrates; D002800:Cholinesterase Inhibitors; D003650:Decamethonium Compounds; D011194:Potassium Isotopes; D013438:Sulfhydryl Compounds; D007531:Isoflurophate; D009388:Neostigmine; D010042:Ouabain; D010830:Physostigmine; D002794:Choline; D000109:Acetylcholine; D011188:Potassium